Access Bio Statistics

Total Valuation

Access Bio has a market cap or net worth of KRW 118.89 billion. The enterprise value is -231.97 billion.

Market Cap	118.89B
Enterprise Value	-231.97B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Access Bio has 35.17 million shares outstanding. The number of shares has increased by 12.74% in one year.

Current Share Class	n/a
Shares Outstanding	35.17M
Shares Change (YoY)	+12.74%
Shares Change (QoQ)	-0.74%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.28%
Float	26.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.17
PB Ratio	0.20
P/TBV Ratio	0.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	8.27
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	7.15

Financial Position

The company has a current ratio of 14.77, with a Debt / Equity ratio of 0.10.

Current Ratio	14.77
Quick Ratio	13.82
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-1.83
Interest Coverage	-15.12

Financial Efficiency

Return on equity (ROE) is -4.76% and return on invested capital (ROIC) is -4.30%.

Return on Equity (ROE)	-4.76%
Return on Assets (ROA)	-4.21%
Return on Invested Capital (ROIC)	-4.30%
Return on Capital Employed (ROCE)	-7.11%
Revenue Per Employee	541.25M
Profits Per Employee	-277.64M
Employee Count	101
Asset Turnover	0.08
Inventory Turnover	2.31

Taxes

Income Tax	-8.47B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.29% in the last 52 weeks. The beta is 0.29, so Access Bio's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-37.29%
50-Day Moving Average	4,041.30
200-Day Moving Average	5,037.78
Relative Strength Index (RSI)	36.16
Average Volume (20 Days)	86,344

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Access Bio had revenue of KRW 54.67 billion and -28.04 billion in losses. Loss per share was -767.87.

Revenue	54.67B
Gross Profit	5.83B
Operating Income	-45.66B
Pretax Income	-37.20B
Net Income	-28.04B
EBITDA	-24.92B
EBIT	-45.66B
Loss Per Share	-767.87

Full Income Statement

Balance Sheet

The company has 411.94 billion in cash and 59.49 billion in debt, giving a net cash position of 352.45 billion or 10,020.27 per share.

Cash & Cash Equivalents	411.94B
Total Debt	59.49B
Net Cash	352.45B
Net Cash Per Share	10,020.27
Equity (Book Value)	602.91B
Book Value Per Share	17,273.79
Working Capital	413.40B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -30.52 billion and capital expenditures -1.91 billion, giving a free cash flow of -32.43 billion.

Operating Cash Flow	-30.52B
Capital Expenditures	-1.91B
Free Cash Flow	-32.43B
FCF Per Share	-922.03

Full Cash Flow Statement

Margins

Gross margin is 10.67%, with operating and profit margins of -83.53% and -51.30%.

Gross Margin	10.67%
Operating Margin	-83.53%
Pretax Margin	-68.05%
Profit Margin	-51.30%
EBITDA Margin	-45.58%
EBIT Margin	-83.53%
FCF Margin	n/a

Dividends & Yields

Access Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.74%
Shareholder Yield	-12.74%
Earnings Yield	-23.59%
FCF Yield	-27.28%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Access Bio has an Altman Z-Score of 3.49.

Altman Z-Score	3.49
Piotroski F-Score	n/a